Quadrature Capital’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-41,649
Closed -$1.63M 1269
2023
Q1
$1.63M Buy
41,649
+24,363
+141% +$1.19M 0.04% 315
2022
Q4
$914K Buy
+17,286
New +$842K 0.03% 366
2021
Q4
Sell
-7,412
Closed -$408K 993
2021
Q3
$408K Buy
+7,412
New +$388K 0.01% 429
2021
Q2
Sell
-6,161
Closed -$312K 1282
2021
Q1
$312K Buy
+6,161
New +$342K 0.02% 615
2020
Q1
Sell
-5,363
Closed -$217K 748
2019
Q4
$217K Buy
+5,363
New +$188K 0.01% 437

Other funds holding SILK

Quadrature Capital's SILK Position: Q2 2023 in Review

Quadrature Capital sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q2 2023, closing a stake of 41,649 shares — an estimated $1.63M sold.

Quadrature Capital first reported a position in SILK in Q4 2019 and held it in 5 quarters. The position peaked at $1.63M in Q1 2023. 173 funds tracked by Wall St. Rank hold SILK as of Q2 2023.

  • Quadrature Capital reported no remaining Silk Road Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Quadrature Capital sold 41,649 Silk Road Medical, Inc. Common Stock shares in Q2 2023, an estimated $1.63M.
  • Quadrature Capital first reported a position in Silk Road Medical, Inc. Common Stock in Q4 2019 and held it in 5 quarters.
  • Quadrature Capital's Silk Road Medical, Inc. Common Stock position peaked at $1.63M in Q1 2023.
  • 173 funds tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q2 2023.

Based on Quadrature Capital's 13F filing for Q2 2023, filed 14 Aug 2023.